Healthy men help track new Drug's journey through the body
NCT ID NCT04634812
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study looked at how a single dose of the experimental drug KBP-5074 is absorbed, broken down, and eliminated in 7 healthy men. Researchers measured radioactivity in blood, urine, and feces to understand the drug's path. The goal was not to treat any disease, but to gather basic information for future studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- KBP-5074
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Covance Clinical Research Unit Inc.
Madison, Wisconsin, 53704, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test